Cosmos

What Cosmos does

Cosmos Limited is a Nairobi-based pharmaceutical manufacturer founded in 1978 by Prakash Patel, producing affordable generic human medicines and veterinary products from a GMP-certified facility in the Industrial Area. The company operates high-volume tablet production at approximately 6.9 million tablets per month across diabetes (2.5M), statins (2.1M), cardiovascular (1.5M), and other categories (0.8M), supplemented by liquid suspension filling, an in-house R&D laboratory, and world-class analytical and formulation development capabilities. Its therapeutic portfolio spans CNS, anti-infective, gastrointestinal, cardiovascular, respiratory, allergy, diabetes, urology, nutrition, and corticosteroid medications, alongside branded consumer health products (Cosflora probiotic, Coscof cough syrup range) and veterinary medicines (Petdog Ascaten-P dewormer, Animal Coccid).

The business model centers on manufacturing and selling generic pharmaceuticals at price points up to 50% below originator equivalents, generating revenue through a distributor-led channel rather than direct sales. Cosmos operates through regional distributors in seven East and Central African countries: Jilichem Limited in Tanzania, Astra Pharma and Eram in Uganda, Multiphar in Rwanda and Burundi, Medix Care in Botswana, and Pharma Solutions in Malawi, with KEMSA serving as the government channel in Kenya. Customers span healthcare professionals (B2B), individual consumers reached through website-based generic inquiry forms (B2C), livestock farmers and pet owners (veterinary), and government health programs including ARV distribution through partnerships with WHO, CHAI, KEMSA, and global pharmaceutical companies.

Cosmos has built a defensible quality and regulatory position through the European PICS certification (2008), USAID certification (2015), a GSK/Boehringer Ingelheim voluntary licence for ARV manufacturing (2004), and a GMP tablet block constructed in 2007. It maintains strategic relationships with WHO, the Pharmaceutical Society of Kenya, Medical Access, MEDS, and Chemonics, which extend its reach into donor-funded and public-sector procurement. The company remains privately held by the founding family, has 101-250 employees, and reports no external funding or M&A activity beyond an early-stage wholesale acquisition in 1984.

Name

Cosmos

Legal name

Cosmos Limited

Website

https://cosmos-pharm.com

Company type

Private

Founded year

1978

Operating status

Operating

Headcount range

101–250 employees

Short description

Cosmos Limited is a Nairobi-based pharmaceutical manufacturer founded in 1978 that produces affordable generic medicines and veterinary products, distributed across seven East and Central African countries through regional wholesalers and government health programs.

Ownership category

akta.pro rank

Product category

Generic Pharmaceutical Manufacturing

NAICS

Pharmaceutical Preparation Manufacturing (325412), Drugs and Druggists' Sundries Merchant Wholesalers (42421)

SIC

Pharmaceutical Preparations (2834), Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)

akta.pro primary industry

Generic & Private-Label Veterinary Pharmaceuticals (HLAMAEAM)

akta.pro secondary industries

Parasiticides & Ectoparasite Control (Flea/Tick/Heartworm) (HLAMAEAD), Antimicrobials & Anti-infectives (HLAMAEAE)

Keywords

• Generic pharmaceutical manufacturing
• Veterinary medicines
• Cough syrups
• Probiotic supplements
• Antiretroviral manufacturing

Headquarters

HQ city

Nairobi

HQ country

Kenya

HQ region

Africa

Offices2 records

Markets served

GTM type

B2B and B2C

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Operations, Personnel, Technology or R&D, Infrastructure, Marketing or Sales

Revenue model

1. Pharmaceutical Product Sales: Manufacturing and selling generic pharmaceutical medicines including tablets, syrups, and veterinary products through distributor network and direct B2C inquiries

Pricing tiers

Go-to-market motion1 record

Distribution channels1 record

Marketing channels3 records

Core offering

Cosmos Limited manufactures and sells affordable generic human pharmaceuticals across therapeutic categories including CNS, antiinfective, gastrointestinal, cardiovascular, respiratory & allergy, diabetes, urology, nutrition, and corticosteroids, as well as antiretroviral medicines under voluntary license from GSK and BI. The company also manufactures veterinary products for livestock and pets (dewormers, anti-coccidial treatments) and consumer health brands such as the Cosflora probiotic range and Coscof cough syrups. Production is carried out at a GMP-certified facility in Nairobi and distributed via a regional wholesaler network across East and Central Africa.

Product overview

Cosmos is a pharmaceutical manufacturer offering a diverse portfolio of generic medicines and veterinary products. The core offerings include therapeutic medicines across categories such as CNS, Antiinfective, Gastro, Cardiovascular, Respiratory & Allergy, Diabetes, Urology, Nutrition, and Corticosteroids. Consumer health products include Cosflora probiotic formula and the Coscof cough syrup range. The company also manufactures veterinary products including Petdog Ascaten-P dewormer and Animal Coccid for livestock health. Cosmos positions itself as a provider of high-quality, affordable generic medicines with a focus on East and Central African markets.

Differentiator

Problem solved

Functional benefit

Brands

• Cosflora: Probiotic formula for healthy gut - a multi-faceted probiotic formula designed to reach the gastro-intestinal tract through a protective matrix, repairing the intestinal lining to restore gut health and immune function.
• Coscof
• PETDOG Ascaten-P

Products and services

• Cosflora Probiotic Formula Multi-faceted probiotic formula designed to reach the gastro-intestinal tract through a protective matrix technology that repairs the intestinal lining to restore gut health and immune function; sold as a consumer health product.
• Coscof Cough Syrups (Coscof, Coscof DM, Coscof C, Coscof Bromsal)

Quantifiable outcome

• Up to 50% savings on monthly medicine expenses for consumers

Named customers4 records

Segments3 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature6 records

Partnerships

16 partnerships are on record, tiered core and major.

• World Health Organization (WHO)coreStrategic or Co-development PartnerWHO partnership under strategic partners section, indicating collaboration on global health initiatives and standards
• Pharmaceutical Society of Kenya (PSOK)coreStrategic or Co-development PartnerProfessional pharmacy association partnership for industry standards and professional development
• Medical AccesscoreStrategic or Co-development PartnerHealthcare access partnership focused on improving medicine availability
• MEDScoreStrategic or Co-development PartnerMedical Equipment and Supplies partnership for pharmaceutical distribution
• KEMSA (Kenya Medical Supplies Authority)coreChannel Partner/ Reseller/ DistributorGovernment healthcare procurement authority, key distributor for essential medicines in Kenya
• CHMPmajorStrategic or Co-development PartnerStrategic health partnership for pharmaceutical standards and distribution
• ChemonicsmajorStrategic or Co-development PartnerInternational development consulting firm specializing in health systems strengthening
• CHAI (Clinton Health Access Initiative)majorStrategic or Co-development PartnerGlobal health organization focused on expanding access to essential medicines and healthcare
• GlaxoSmithKline (GSK) and Boehringer Ingelheim (BI)coreStrategic or Co-development PartnerVoluntary licensing agreement (2004) enabling Cosmos to manufacture antiretroviral medicines, demonstrating international pharmaceutical company trust
• Jilichem LimitedcoreChannel Partner/ Reseller/ DistributorRegional distributor for Tanzania based in Dar es Salaam, handling Cosmos product distribution in the country
• Astra Pharma (U) LtdcoreChannel Partner/ Reseller/ DistributorRegional distributor for Uganda based in Kampala, distributing Cosmos products in the Ugandan market
• Eram (U) LtdcoreChannel Partner/ Reseller/ DistributorRegional distributor for Uganda based in Kampala, distributing Cosmos products in the Ugandan market
• Multiphar Rwanda LtdcoreChannel Partner/ Reseller/ DistributorRegional distributor for Rwanda based in Kigali, distributing Cosmos products in the Rwandan market
• Multiphar Pharmacie GrossistecoreChannel Partner/ Reseller/ DistributorRegional distributor for Burundi based in Bujumbura, distributing Cosmos products in the Burundian market
• Medix Care (PTY) LtdcoreChannel Partner/ Reseller/ DistributorRegional distributor for Botswana based in Gaborone, distributing Cosmos products in the Botswana market
• Pharma Solutions LtdcoreChannel Partner/ Reseller/ DistributorRegional distributor for Malawi based in Blantyre, distributing Cosmos products in the Malawian market

Scale indicators7 records

Recent moves5 records

Expansion highlights5 records

Regional players

• Pharma Dynamics: South African generics manufacturer focused on chronic disease medicines (cardiovascular, diabetes). Comparable to Cosmos in therapeutic portfolio targeting African public and private markets.
• Drugs and Pharmaceutical Kenya (DPK): East African pharmaceutical distributor and manufacturer with regional reach. Comparable to Cosmos as a regional player operating across East African generics distribution channels.

Broad incumbents

• Cipla: Indian-headquartered global generic manufacturer with a significant Africa presence (including ARVs via partnerships), competing head-to-head with Cosmos in affordable essential medicines and HIV therapies across East and Southern Africa.
• Aurobindo Pharma: Indian generic manufacturer with global ARV leadership and growing African distribution. Competes with Cosmos in donor-funded tenders and affordable essential medicines across East and Central Africa.
• Strides Pharma Science: Indian generic pharmaceutical manufacturer with active Africa footprint and ARV capacity. Comparable to Cosmos in supplying affordable generics and ARVs to African public health programmes.
• Lupin Pharmaceuticals: Indian generic manufacturer with established Africa business in cardiovascular, diabetes, and anti-infectives — overlapping therapeutic categories with Cosmos and competing on tender pricing.
• Aspen Pharmacare: Largest pharmaceutical manufacturer in Africa, headquartered in South Africa, with extensive generic and branded pharma manufacturing across the continent. Comparable to Cosmos as a leading African generics platform serving similar public-sector and consumer health markets.
• Adcock Ingram: South African pharmaceutical manufacturer with a broad generics and OTC portfolio, well-established distribution across Africa. Comparable to Cosmos in manufacturing scale, therapeutic breadth, and regional African footprint.

Direct peers

• Universal Corporation / Uni-Pharma: Kenyan pharmaceutical manufacturer focused on generic essential medicines. Closely comparable to Cosmos in therapeutic categories, manufacturing approach, and East African distribution.
• Beta Healthcare Group: Kenyan pharmaceutical manufacturer producing generic human and animal health products. Directly comparable to Cosmos as a domestic Kenyan generic manufacturer targeting the same B2B healthcare professional and consumer segments.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

• Xx.com/Cosmos_Cares
• Facebookfacebook.com/CosmosCares
• LinkedInlinkedin.com/company/cosmos-limited

Compliance6 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Cosmos